TAKE Solutions Limited has successfully completed its Extra Ordinary General Meeting held on March 7, 2026, with shareholders approving all four proposed resolutions through remote e-voting and e-voting facilities during the meeting.

Meeting Overview and Compliance

The Extra Ordinary General Meeting was conducted at 12:00 noon through Video Conferencing and Other Audio-Visual Means in accordance with regulatory requirements. The company submitted voting results and scrutinizer's report to BSE Limited and National Stock Exchange of India Limited in compliance with Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

M/s. Hemang Satra & Associates, Practicing Company Secretaries, served as the scrutinizer for the voting process. The cut-off date for identifying eligible voting members was February 28, 2026, with remote e-voting conducted from March 4-6, 2026.

Voting Results Summary

The meeting demonstrated strong shareholder participation with 44190476 votes polled out of 147934000 total shares, representing 29.87% voter turnout. All resolutions received overwhelming support from shareholders.

Director Appointments Approved

Shareholders approved the regularization of appointments for two Non-Executive Non-Independent Directors. Mr. Parmeshvar Dhangare (DIN: 11410125) received approval with 44190468 votes in favor and only 8 votes against, representing 100.00% support. Similarly, Mr. Vilas Munis (DIN: 11533598) was approved with 44190443 votes in favor and 33 against, achieving 99.99% approval.

Auditor Change and Office Relocation

The company received shareholder approval for appointing M/s. Venkat and Mangaa LLP, Chartered Accountants, as Statutory Auditors to fill the casual vacancy caused by the resignation of M/s. Sundar Scini & Scidhar Chartered Accountants. This resolution passed with 44190452 votes in favor.

The special resolution for shifting the registered office from Tamil Nadu to Maharashtra was approved with 44190350 votes in favor and 126 against, representing 99.99% approval from voting shareholders.

Scrutinizer's Confirmation

Hemang Satra, Proprietor of M/s Hemang Satra & Associates (Membership No. ACS 54476), confirmed that all resolutions were passed with requisite majority. The scrutinizer's report validated the voting process conducted through CDSL's remote e-voting platform, ensuring transparency and compliance with regulatory requirements.

TAKE Solutions Limited announced a strategic integration of Anthropic's Claude AI capabilities across its healthcare technology platforms on February 21, 2026. This development represents a significant advancement in the company's mission to build scalable, intelligent, and preventive healthcare solutions designed to improve outcomes and enable data-driven healthcare delivery.

Strategic AI Integration Across Healthcare Platforms

The integration of Anthropic's Claude advanced AI capabilities will strengthen TAKE Solutions' upcoming platforms, including its AI-driven Preventive Healthcare Platform, One Minute Clinic, and Unified AI Marketplace. These platforms are being designed to transition healthcare from a reactive treatment model to a predictive and preventive care ecosystem.

Enhanced Capabilities and Operational Benefits

The AI integration aims to deliver comprehensive improvements across multiple healthcare domains:

• Enhanced clinical decision intelligence through faster and more accurate data analysis
• Improved productivity across healthcare workflows, diagnostics, and patient engagement
• Delivery of highly personalized health insights and preventive care recommendations
• Seamless integration of AI applications through the Unified AI Marketplace
• Scaled One Minute Clinic model for faster, intelligent, and accessible healthcare services

Platform-Specific Enhancements

The company's Unified AI Marketplace is envisioned as a scalable platform enabling healthcare stakeholders, including hospitals, diagnostic centers, pharmaceutical companies, and wellness providers, to access and deploy AI solutions efficiently. The addition of Anthropic capabilities significantly strengthens the platform's ability to process complex medical, clinical, and operational data securely and at scale.

The Preventive Healthcare Platform leverages artificial intelligence to identify early health risks, recommend corrective actions, and enable proactive healthcare management, addressing one of the fastest-growing segments of the global healthcare industry.

The One Minute Clinic initiative, designed to deliver rapid health assessments and intelligent recommendations, will benefit from enhanced AI capabilities, enabling faster report generation, improved accuracy, and better patient experience.

Leadership Perspective

Chairman Parmeshvar Dhangare emphasized the strategic importance of this development, stating that artificial intelligence is becoming the foundation of next-generation healthcare. He noted that the integration of advanced Claude AI capabilities significantly enhances the company's technology stack and strengthens its ability to build scalable, intelligent healthcare platforms, improving operational efficiency and supporting the vision of transforming healthcare through predictive and preventive intelligence.

Market Positioning and Future Outlook

The global healthcare industry is undergoing a structural shift toward AI-enabled preventive care, digital diagnostics, and intelligent healthcare platforms. With continued investments in advanced AI infrastructure, TAKE Solutions is positioning itself at the forefront of this transformation, building scalable platforms designed to serve large healthcare networks, diagnostic providers, and life sciences organizations globally.